Detalles de la búsqueda
1.
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patients.
Ann Oncol
; 29(4): 973-978, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29390048
2.
Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations.
Ann Oncol
; 28(11): 2793-2798, 2017 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28945881
3.
Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.
Ann Hematol
; 95(9): 1399-410, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27334946
4.
Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML--long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL).
Ann Oncol
; 26(7): 1434-40, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25922062
5.
Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL.
Ann Oncol
; 25(9): 1800-1806, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24928834
6.
Real-world analysis of teclistamab in 123 RRMM patients from Germany.
Leukemia
; 38(2): 365-371, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38245601
7.
Treatment of primary mediastinal large B cell lymphoma with an alternating chemotherapy regimen based on high-dose methotrexate.
Ann Hematol
; 88(5): 433-9, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18853160
8.
Persistent multi-scale fluctuations shift European hydroclimate to its millennial boundaries.
Nat Commun
; 9(1): 1767, 2018 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29720588
9.
Establishment and maintenance of DNA methylation patterns in mouse Ndn: implications for maintenance of imprinting in target genes of the imprinting center.
Mol Cell Biol
; 21(7): 2384-92, 2001 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11259587
10.
Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia.
Leukemia
; 20(4): 707-14, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16482208
11.
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.
Leukemia
; 31(11): 2398-2406, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28804124
12.
Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer.
Prostaglandins Leukot Essent Fatty Acids
; 75(6): 429-34, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17034997
13.
Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO).
J Cancer Res Clin Oncol
; 142(1): 305-15, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26407768
14.
Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry.
J Hematol Oncol
; 9: 18, 2016 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26944254
15.
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial.
Leukemia
; 30(2): 261-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26283567
16.
Karyotype complexity and prognosis in acute myeloid leukemia.
Blood Cancer J
; 6: e386, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26771812
17.
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance Leukemia.
Leukemia
; 30(3): 555-61, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26522083
18.
Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
Bone Marrow Transplant
; 36(12): 1083-8, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16247435
19.
Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial.
Leukemia
; 29(5): 1060-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25434303
20.
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy.
Bone Marrow Transplant
; 21(12): 1171-5, 1998 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-9674847